Objectives
After participating in this educational activity, attendees should be able to:
1| Describe current guideline-recommended lipid targets and risk stratification strategies for patients with dyslipidemia.
2| Review stepwise treatment algorithms for the management of dyslipidemia based on patient-specific cardiovascular risk.
3| Compare mechanisms of action, efficacy, and clinical roles of available lipid-lowering therapies.
4| Apply guideline-directed treatment strategies to optimize pharmacologic management of dyslipidemia in clinical practice.
Presenter(s):
Brittney Brzoska, PharmD
Brittney Brzoska, PharmD
PGY2 Ambulatory Care Pharmacy Resident
Baystate Medical Center
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Brittney Brzoska, PharmD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Session date:
03/16/2026 - 2:00pm to 3:00pm EDT
Location:
Hybrid
United States
See map: Google Maps
Add to calendar:
- 1.00 ACPE Contact Hours
- 1.00 ACPE Technician contact hours
Facebook
X
LinkedIn
Forward